ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2017

PARP inhibitor and chemotherapy combination trials for the treatment of advanced malignancies: does a development pathway forward exist?

U A Matulonis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.